CERo Therapeutics Holdings, Inc. (CERO) NASDAQ

0.46

+0.0146(+3.28%)

Updated at June 02 03:14PM

Currency In USD

CERo Therapeutics Holdings, Inc.

Address

201 Haskins Way

South San Francisco, CA 94080

United States of America

Phone

650-407-2376

Sector

Healthcare

Industry

Biotechnology

Employees

8

First IPO Date

November 30, 2021

Key Executives

NameTitlePayYear Born
Mr. Christopher B. Ehrlich M.B.A.Chief Executive Officer & Chair1.08M1970
Mr. Andrew Albert Kucharchuk M.B.A.Chief Financial Officer252,0001981
Dr. Kristen Pierce Ph.D.Chief Development Officer360,0001971
Dr. Lawrence Corey M.D.Co-founder & Head of Scientific Advisory Board01947

Description

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.